Here's how Trava Health rates on each part of the Selene Care Standard. The two that matter most — PMOS (PCOS) fit and Endo-aware care — get a single star (full, half, or empty). The five care basics get a simple check. Price is shown but never part of the rating.
Trava's appeal is simplicity at the point of entry: $198 all-inclusive at the starting dose, with compounded semaglutide and tirzepatide available and direct provider contact. If you are just beginning, the arithmetic is easy.
Titration runs on standard ladders rather than individualised protocols, and there is no PMOS or insulin-resistance programme and no hormonal or endo context. The model is medication delivery, and it is honest about that.
No PMOS (PCOS) or insulin-resistance program.
No hormonal or endo context built in.
Offers compounded semaglutide and tirzepatide on standard titration ladders, not individualized.
Aims for 24-hour replies, but publishes no guaranteed response time for urgent questions.
A medication-delivery model with no structured maintenance or taper.
The $198 rate is all-inclusive at the starting dose; higher doses are priced up to about $319, and cancellation terms aren't published.
Direct provider contact, but no ongoing community or behavior-change coaching.
The $198 rate is genuinely all-inclusive at the starting dose, which is a real advantage over providers that add consultation and adjustment fees. Higher doses are priced up to about $319, so the figure moves as you titrate — plan from the upper number rather than the lower one if you expect to progress. You get direct provider contact, though no ongoing community or behaviour-change coaching.
A standard ladder assumes a typical response and has no built-in mechanism for someone who needs longer at a step or a different increment. The service aims for 24-hour replies but publishes no guaranteed response time for urgent questions, and cancellation terms are not published. There is no structured maintenance or taper.
Send these to Trava Health and keep the answers.
Trava is clear and affordable at the entry point and less so as you titrate, which is the main thing to plan around. It rates low on this Standard because it addresses neither condition and runs standard ladders where individualised dosing is what this reader usually needs.
This reflects what Trava Health publishes, and providers revise terms without announcing it, so treat it as a starting point and confirm the details yourself. Selene is editorial and independent — not affiliated with Trava Health, and nothing here is medical advice. GLP-1 medications are not a treatment for endometriosis.